Work

The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset

Year: 2017

Type: review

Source: Expert Opinion on Biological Therapy

DOI: 10.1080/14712598.2018.1389885

Authors: Francesco Panza, Davide Seripa, Madia Lozupone, Vincenzo Solfrizzi, Bruno P. Imbimbo, Maria Rosaria Barulli, Rosanna Tortelli, Rosa Capozzo, Paola Bisceglia, Andrea Dimitri, Roberta Stallone, Vittorio Dibello, Nicola Quaranta, Antonio Daniele, Antonello Bellomo, Antonio Greco, Giancarlo Logroscino

Institutions: Casa Sollievo della Sofferenza, University of Bari Aldo Moro, Chiesi (Italy), Università Cattolica del Sacro Cuore

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Ministero dell'Università e della Ricerca

OpenAlex ID: W2766042976

FWCI: 0.605

Cites: 89

Cited by: 40

Related to: 10